Naturally occurring genetic variation is quantified for survival time of adult Drosophila melanogaster exposed to chronic ingestion of the drugs nicotine, caffeine, dopamine, tyramine and octopamine. Responses to nicotine, tyramine and octopamine were genetically correlated in both sexes, while caffeine response correlated with starvation resistance, but it also apparent that there is genetic variation that is specific for each of the drugs. Females tend to be more resistant than males to nicotine and caffeine, but sex-by-genotype interactions are also seen for these drugs and for the response to dopamine. A very unusual and complex genetic architecture was observed in crosses among lines with a range of responses to caffeine ingestion. Additive and dominance components were clearly seen from the analysis of F1 individuals, but increased female resistance to caffeine in backcross generations and increased male sensitivity in F2 generations confused generation means analysis of possible epistatic contributions. The possible sources of variance are discussed, and it is concluded that quantitative transposon mutagenesis may be the most direct way to isolate genes that affect drug resistance in D. melanogaster.
Introduction
Dissecting the genetic architecture of complex multifactorial traits, such as drug response and behavior is a complicated task. Studies associating genes with behaviors such as depression and alcoholism have been undertaken in mice and humans (McLeod and Evans, 2001) , but have met with mixed success and no clear picture of the relationship between genetic and pharmacological variation has emerged. The fruitfly, Drosophila melanogaster, offers many advantages as a model system for pharmacogenetic analysis because of resources such as the genome sequence, SNP databases and the availability of mutant lines. Flies can also be grown in controlled environments and their genetic background can be manipulated. Here we present an initial characterization of the architecture of survival time upon chronic drug exposure in the Drosophila.
Genetic approaches have already been used to study several behaviors in flies (Sokolowski, 2001) , including learning (Dubnau and Tully, 1998) , reflex behaviors in decapitated flies (Hirsh, 1998; Ashton et al., 2001) , heart rate (Johnson et al., 1998; Robbins et al., 1999) , alcohol-induced behavior (Heberlein, 2000) and drug response (Zimmering, 1977) . Most of these studies have adopted Mendelian genetic strategies, but given anecdotal reports of the effect of genetic background, it is also important to characterize the genetic architecture of naturally occuring variation for behaviors such as drug susceptibility. The drugs that we have studied include the biogenic monoamines dopamine, octopamine and tyramine, as well as caffeine and nicotine. Biogenic monoamines are neurotransmitters involved in synaptic transmission that are highly conserved in most animals (Walker 1996) . Monoamines are believed to modify and regulate moods, various personality traits and environmental responses, as well as having physiological effects.
Previous studies have shown that monoamines affect locomotor activity (Hirsh, 1998) and heart rate (Ashton, 2001) and are lethal when added to the diet. In addition, complete loss of monoamine production is also lethal (Bainton, 2000) . The addition of caffeine to the diet of Drosophila causes an increase in the frequency of chromosome loss in larvae and has a mutagenic effect (Clark, 1968) . Caffeine is also lethal to adult Drosophila melanogaster (Zimmering, 1977) , and in smaller concentrations decreases longevity and fecundity in Drosophila prosaltans (Itoyama, 1998) . Further, caffeine sensitivity has been shown to vary among populations and between males and females (Zimmering, 1977) , but the source of these differences are not known. As with other organisms, it presumably has a polygenic basis reflecting variation in factors such as rates of drug absorption, metabolism, and secretion (Evans and Relling, 1999) . The effects of nicotine in Drosophila have not been studied in depth, but in mice nicotine has been shown to affect the release of dopamine and serotonin when added to drinking water (Pietila, 2000) . Given that the receptors for these neurotransmitters are highly conserved across animal taxa (Hen, 1993; Fryxell, 1995) , it is reasonable to suppose that there will be some similarities in drug response between flies and mammals. In the absence of receptor mutants in flies, we have initiated a quantitative genetic analysis of pharmacological variation in flies, and show here that sex, genotype, and interaction effects are prevalent for survival time on several drugs, and that the genetic effects are largely independent for each drug.
Materials and Methods

(i) Lines and Assay
Parental lines used in this study consisted of sixteen isofemale lines of Drosophila melanogaster. These flies were collected from the Kerrytown Fruit Market in Ann Arbor, Michigan in 1996. The stocks were maintained on standard cornmeal medium with yeast at 25 0 C on a 12-hour light/dark cycle. Flies were collected between one and three days after emergence and were kept on standard cornmeal media for three days prior to scoring. These flies were then separated by sex, and ten flies of each sex were placed separately in vials with drug food. The number of live flies was counted every twelve hours until all of the flies were dead. Ten replicate vials of each line and sex were scored.
Five drug treatments were used to test for drug sensitivity. Octopamine (20 mg/ml), tyramine (20 mg/ml), dopamine (40 mg/ml), nicotine (3 µl/ml) and caffeine (10 mg/ml) were directly dissolved in molten fly food just prior to addition to empty vials. Drugged food was used between one and four days after preparation. Starvation resistance on agar medium was also measured as a control for variation in overall fitness between the lines and sexes.
Crosses were produced of the extreme lines for caffeine resistance. F1 and F2 generations of the extreme parental lines (i.e., high x low) as well as the reciprocal crosses were measured. Crosses were also made of the high x high (A3 and A6), low x low (A2 and A19), no sex effect x no sex effect (A7 and A16), and sex effect (A2 and A3) x no sex effect. In each case, one male and one virgin female were used to found five independent replicates, from which two sets of 10 males and 10 females were assayed for time to mortality. The replicates were established over several months, involving independently prepared food and drug batches.
(ii) Statistical Analysis Analysis of variance was performed using SAS Proc GLM on the survival time for each individual fly, computed as the midpoint of the 12 hour interval in which the fly died. This ensured that among fly variability is the source of residual error, but Vial effects were also included in the model for response to each drug as follows, with Vial and Line as random effects and Sex a fixed effect:
Genetic correlations between the drug treatments reported in Table 2 for each sex separately were calculated according to Robertson (1959) as:
where MS represents the mean square in a two-factor ANOVA for the residual error, Line, or Drug×Line interaction.
Further analysis of caffeine resistance was performed by generation means analysis, implementing the methods of Kearsey and Pooni (1996) and Gilchrist and Partridge (2001) in JMP software Version 3 (SAS Institute, 1995). The observed generation means for survival times were used to estimate genetic parameters. First, a regression model was constructed containing only the mean survival time. To this model, other regression terms were added, starting with additive (a) and dominance (d) effects, then digenic epistatic (aa, ad, or dd), maternal (am or dm), and sex-linked effects. Each parameter was added stepwise, and estimated parameter values were used to calculate expected generation means. The expected and observed generation means were compared using a χ 2 test, and only parameters that improved the model were kept at each step. Table 3 indicates the parameters that significantly improved the model when added, as well as the effect and significance of the indicated parameters. Note that some parameters improve the overall fit of the model without themselves being significant.
Results
(i) Genetic variation for drug resistance
Sixteen isofemale lines of Drosophila melanogaster were assayed to gauge the amount of genetic variation present for survival time on five drug treatments. Flies between three and six days of age were separated by sex and placed in vials containing standard cornmeal media mixed with one of the drugs. For some of the drugs, behavioral changes such as grogginess (nicotine and dopamine) or hyperactivity (caffeine) were observed within 12 hours of transfer to the drug food. The number of flies that were alive in each vial was counted every twelve hours until all of the ten flies in each vial were deceased. Concentrations of the drugs were chosen on the basis of preliminary titration experiments (data not shown) such that the mean survival time for most lines ranged from between 24 and 96 hours. Line means are shown for starvation media, tyramine, octopamine, and dopamine, and by sex for nicotine and caffeine, in Figure 1 . The range of variation was clearly greater for the latter three drugs. Very similar mean survival times for each line and sex were inferred from the point of inflexion of Kaplan-Meier survival plots. Age at death was approximately normally distributed within lines for all drugs.
Analysis of variance was used to assess the significance of the contributions of genotype, sex, genotype-by-sex interaction, and within and among vial effects, to the variation. The F-ratios associated with each effect and associated significance levels are indicated along with the estimated variance component for the random effects, in Table 1 . For nicotine and caffeine, genotype (Line) and sex as well as the interaction between these factors, were highly significant. In general, females are twice as resistant to nicotine as males and 50% more resistant to caffeine, so that the absolute differences between the sexes tends to increase with overall levels of resistance. There was no overall effect of sex on the response to the other drugs, although a small interaction effect, largely attributable to a few lines, was observed for dopamine and tyramine. Genotype differences were only marginally significant for the monoamines tyramine and octopamine, partly as a consequence of relatively large among vial differences for these drugs. Heritability of survival time on each drug was estimated in Table 1 as half the proportional contribution of the genotype and genotype-by-sex variance components, and ranges up to 0.23. As reported by others (Hoffmann et al., 2001; Kennington et al., 2001; Harshmann et al., 1999) , starvation resistance also shows considerable genetic variation, the heritability of which is increased relative to that of drug resistance in our experiments by the low among individual variance, despite the similar distributions of line means.
A major source of potential experimental error in these studies is the consistency of drug delivery to flies. For dopamine, nicotine, and caffeine, vial effects were either non-significant or contributed just a few percent of the total variance, suggesting that these drugs were reproducibly dissolved in the cornmeal medium, which was prepared in multiple batches at different times. Vial effects were higher for tyramine, consistent with the low solubility of this compound, and for octopamine, reflecting the general absence of sex and genotype effects for ingestion of this drug. The residual error term in each treatment indicates differences among flies within vials, and presumably includes effects of differential ingestion as well as physiological responses to the drugs. There is no way to tease these apart, but we note that these error terms are in the same range as those observed for many morphological traits. Even for drugs such as octopamine with marginally significant line effects and high error rates, clear differences can still be observed between extreme lines for survival.
(ii) Correlations among drug responses
To determine whether genotype-specific drug responses merely reflected generalized differences in fitness among lines, for example due to fixation of deleterious alleles, the genetic correlations among lines were examined. Line means normalized to a standard deviation of one and mean of zero are plotted in Figure 2 , which is dominated by the crossing of line means. Genetic correlation coefficients are given for each sex in Table 2 , with females above the diagonal and males below it. In general, correlations among treatments are low, further implying that the genetic differences among lines that contribute to extreme drug resistance or sensitivity are different for each drug. A remarkable example of this is line A11, which is hyper-resistant to dopamine alone among the five drugs studied here.
However, there are also trends that suggest some common susceptibility factors. First, caffeine and tyramine sensitivity are significantly correlated with starvation resistance, possibly indicating that some of the response is due to avoidance of food laced with these drugs. Starvation is not the sole cause of caffeine-induced mortality, since several of the lines survive for longer on the drug food than on agar. Further, these drugs are having direct effects on viability since other lines have reduced mortality upon chronic drug exposure. Second, two of the lines, A17 and A19, are among the most sensitive to nicotine, caffeine, tyramine, and dopamine as well as starvation, suggesting poor general metabolic performance. In fact, one of these lines has since been lost due to low fecundity. At the other end of the spectrum, it is noteworthy that the two lines that are most resistant to caffeine (and starvation), A3 and A6, are relatively sensitive to nicotine, while those most resistant to nicotine have intermediate sensitivity to the other drugs. Third, a relatively high correlation was observed between nicotine and tyramine or octopamine, suggesting that these drugs may operate through related physiological systems.
(iii) Additivity and dominance of the caffeine response
To begin to dissect the genetic architecture of drug sensitivity, we performed a series of crosses between lines with extreme responses to caffeine. Caffeine was chosen for further study due to the highly significant genotype, sex, and interaction effects and absence of vial effects for response to this drug. Crosses were designed to assess the degree of dominance for both the overall resistance or sensitivity to caffeine, and for the sex-specificity of the response. Additive, dominance, epistatic and maternal effects were all tested by generation means analysis. Sex-linked effects were also included, but did not improve the fit of the multiple regression in any of the crosses.
As expected, the survival time of F1 progeny of crosses between resistant (A3 or A6) and sensitive (A19 or A2) isofemale lines was intermediate between that of the two parents, as shown in Figure 3 . After addition of reciprocal backcross and F2 data, generation means analysis of these resistant by sensitive crosses was performed for males and females separately (Table 3) , but no consistent explanatory model was observed. Among individual variance increased in the F2 relative to the F1 for some crosses, but the effect was too inconsistent to provide a reliable estimate of the number of genes that may be contributing to the variation. This may reflect insufficient power of the analysis given the high individual variability, or an effect of residual genetic variation in the inbred isofemale lines, and is also consistent with the possibility that drug sensitivity is influenced by a large number of loci of small effect.
Crosses between the two resistant and between the two sensitive lines also indicate that different loci contribute to survival time on caffeine even in isofemale lines with similar phenotypes. In both cases, F1 progeny failed to reproduce the extreme phenotype of the two genetically distinct parents, such that a cross between resistant lines (A3 and A6) gave rise to relatively sensitive F1 means while a cross between two sensitive lines (A2 and A19) gave rise to resistant F1 flies. The possibility of epistatic interactions contributing to drug sensitivity is suggested by the extraordinary observation that F1 female progeny of the two sensitive lines actually have resistance levels similar to those of the most resistant inbred lines. This is observed in the multiple regression models for these crosses, where the dominance by dominance parameters improved the model, and were highly significant (Table 3) .
(iv) Sex specificity of the caffeine response
Characterization of the genetic interactions affecting caffeine-induced mortality is further complicated by highly unusual sex-specific effects in the F2 and BC generations of all crosses involving at least one sensitive (low survival time) parent. As can be seen in Figures 3 and 4 , backcross females in both directions are uniformly more resistant than even the resistant parent. Just as strangely, F2 males are uniformly more sensitive than even the most sensitive parent. These results were repeatably observed in replicates set up at different times, and cannot be attributed to a batch effect of the food since in each case the opposite sex behaved as predicted. In separate analyses, food batch was also found not to significantly affect survival times (not shown).
The unusual sex-specific nature of the response in F2 and BC individuals was also observed in crosses designed to explore the nature of the genotype-by-sex interaction, as shown in Figure 4 . Three lines of evidence imply that the degree of sex-specificity is superimposed on the overall drug response. The first is that overall, the two sexes are genetically correlated for all drug responses, as can be seen in Figure 1 . The second is that a few of the lines have almost no sex effect on caffeine response, while the remainder have a large difference (a similar claim could be made for the nicotine response). This may imply that one or a few loci independently regulate the degree of sex-specificity. The third is that the sex difference is lost in the F1 of four of the crosses between sex-specific (A2 or A3) and phenotypically similar non-sex-specific (A7 or A16) lines. The directional loss of sex-specificity in the A3 by A16 cross may imply the presence of an X-linked factor affecting the dominance of the female resistance to caffeine in A3. However, the unusual female backcross and male F2 effects documented above also appear in these crosses, though for simplicity these results are not included in Figure 4 . We do not have a good explanation for these effects, which defy standard quantitative genetic models.
Discussion (i) Genetic architecture of drug sensitivity and resistance in Drosophila
Given the recent upsurge in interest in human pharmacogenetics, there is a pressing need for the development of model systems for the study of the genetic basis of pharmacological variation. Although the biochemical pathways through which monoamine neurotransmitters are metabolized are fairly well characterized in D. melanogaster, remarkably little is known about the genetics of neurotransmitter receptor function, or more generally drug activity in flies. This is perhaps because much of the behavioral research on this organism has been driven by forward genetic screens for perturbation of specific behaviors such as learning and vision. Nevertheless, the demonstration that there is genetic variation in flies for behaviors such as foraging and ethanol tolerance (Sokolowski, 2001; Bainton 2000) , and for pharmacological traits such as heart rate and autonomic "headless" behaviors (Ashton 2001) , has encouraged us to initiate a genetic dissection of response to chronic drug exposure. In the absence of Mendelian mutants, we have started by characterizing the levels of naturally occurring variation, as this will form a baseline for interpretation of the effects of gene knockouts.
A basic question in behavioral genetics is whether specific phenotypes can be disrupted by single mutations of large effect, or whether many mutations of small effect have diverse and pleiotropic effects on a variety of traits. Several mutations have been uncovered in key genes involved in signal transduction that have remarkably specific consequences such as disruption of a specific step in learning or switching larval feeding behavior (Goodwin et al., 1997; Osborne et al., 1997) . On the other hand, mutations in enzymes that are involved in the biosynthesis and degradation of monoamines are known primarily from their effect on pigmentation (for example ebony, which encodes β-alanyl dopamine synthase, and pale, which encodes tyrosine hydroxylase) and have not been shown to disrupt pharmacology. Similarly, only a couple of the neurotransmitter receptor genes that have been identified have been associated with lesions, and these were isolated by molecular rather than phenotypic screens, suggesting that receptor mutant phenotypes are likely to be subtle. One report has implicated the biological clock pathway in modification of cocaine sensitivity (Andretic, 1999) , but these results may be confounded with the effects of genetic background in the experiment. One of the aims of this study has been to define a trait that may be suitable for genetic screens for aberrant response to drug exposure.
Our key findings can be summarized as follows. (i) There is ample naturally occurring genetic variation for survival time upon chronic ingestion of several drugs including nicotine, caffeine, dopamine and tyramine, although the evidence in relation to octopamine was equivocal. (ii) Survival time may not be the most biologically meaningful trait, but it is easy to score and has moderate heritability and good repeatability, all of which make it simpler (though not necessarily more desirable) for genetic analysis than assays that involve measurement of behavioral responses. (iii) The correlations among drug responses are moderate to non-existent, indicating that much of the genetic variation is specific for one or a few of the drugs. (iv) Females tend to be more resistant than males to nicotine and caffeine, and sex-by-genotype interactions are also seen for these drugs and for the response to dopamine. (v) Preliminary dissection of differences in caffeine sensitivity suggests a complex genetic architecture with many genes of small effect and some dominance for resistance.
Dissection of the genetic architecture of behavioral responses in line crosses is complicated by relative large vial and among individual variance. Our results for caffeine resistance, similar to those of Kennington et al. (2001) in their analysis of the correlated trait of starvation resistance, failed to reveal a consistent picture of the extent or nature of epistatic effects, though these certainly seem to be present. Further dissection of this phenomenon is probably best approached by fine structure QTL mapping of the loci that are responsible for modulation of survivial times on each drug. Unfortunately, though, the most direct interpretation of our data is that drug sensitivity is affected by many genes of small effect. This conclusion is supported by the preliminary results of a screen for P-element insertions in an isogenic background, that suggests that mutations in at least 5% of the genome may affect drug sensitivity, often in a sex and drug-specific manner (A.P. Wagoner and G.G., unpublished data). Cloning of the genes asssociated with these insertions and analysis of interactions among the loci will complement classical quantitative genetic dissection of drug resistance.
The sex-specificity of the response to caffeine is particularly intriguing, in so far as F2 progeny of crosses between any pair of lines always resulted in much reduced male survival times, while backross females showed elevated resistance. This was true even in the case of a cross between two isofemale lines that did not show any difference between the sexes. Sex effects for caffeine resistance have been previously reported, with females of some mutant strains also living longer than males (Zimmering, 1977; Ityoyama, 1998) . Various explanations have been proposed for this, including differences in body size and repair efficiency between males and females. Caffeine is known to cause an increase in the frequency of chromosomal loss in both males and females, but no evidence has been found that caffeine can induce any sex-linked lethal mutations (Clark, 1968) . Our interpretation is that the difference in response between the sexes may be superimposed on the general ability of the flies to resist the drugs. Nevertheless, for all of the drugs, there is a high correlation between the sexes, indicating that common factors influence the response within a line. Investigation of how sex-specific factors interact with these loci will be an essential element of dissection of drug responses, and has implications for understanding the evolutionary dynamics of variation affecting neurotransmitter activity.
(
ii) Sources of variation affecting drug response
Comparison of variation among wild type isolates can only provide indirect information as to the sources of variable drug response. More direct approaches will include cloning of mutations that produce discrete responses, survey of gene and protein expression differences among lines, and characterization of the interactions among candidate loci that affect various processes impinging on pharmacology. Nevertheless, our results provide some insight into the likely sources of variability.
The most obvious source is behavioral variation, namely avoidance of drugged food. The strong correlation between survival on caffeine and on starvation media, for example, especially taken together with the similarity in mean survival times, implies that flies may simply not like the taste of caffeine, and starve themselves to death. In this case, variation in genes involved in taste perception and/or processing of the behavioral response could contribute to the enhanced survival times in several lines. Alternatively, the behavioral response could be more remote, since flies become hyperactive upon exposure to the drug, and food avoidance might relate to altered desire to eat, or to some other induced eating disorder.
It is just as likely that variation in metabolic pathways for drug adsorption, action and elimination (Evans and Relling, 1999) are involved in differential survival. There is a large literature dealing with evolved resistance to insecticides, which often reflects the emergence of detoxifying enzymes. Similarly, human multidrug resistance in cancer patients often involves modification of drug uptake and transport or catabolism. Some of these factors would be expected to be pleiotropic, some drug-specific, and little can be concluded about their involvement in naturally occurring variation from this study.
An arguably more interesting source of variation would be specific pharmacological responses relating to the processing of drug ingestion at multiple cellular levels, from the synapse to modification of gene expression to neural connectivity. Some of these drugs, notably octopamine, also act as hormones in systemic regulation of metabolism, so it is possible that effects on survival are mediated independent of the nervous system. Furthermore, we do not know what happens to the drugs either in the food or after ingestion, so it is impossible to say where their site of action may be.
Microarray studies of exposure of mice and fibroblast cultures both indicate that common signal transduction pathways are affected by chronic exposure to nicotine, and we are currently investigating whether this is also the case in flies. Dopamine and serotonin are believed to have a role in the effects of nicotine in mice (Pietila, 2000; Balfour, 2000) , and may indicate a common biochemical pathway to drug addiction and response (Betz, 2000) . Intriguingly, octopamine and tyramine both cause a dramatic reduction in transcription throughout the genome, commencing as soon as 12 hours after transfer of flies to the drug food (unpublished data), which undoubtedly leads to mortality. Starvation, nicotine, and caffeine do not have this effect, and it will be important to establish the cause of mortality induced by these treatments.
Finally, survival is also likely to be affected by general "fitness" of the flies. This is clear in the case of those lines that are sensitive to all treatments, and so are likely to have fixed deleterious recessive alleles. An extreme interpretation of our results would be that the specific drug responses bear little relation to processing of particular drugs, and rather reflect chance interactions between drugs and fitness factors that segregate in the lines. However, flies that feed on vegetative matter are undoubtedly exposed to a wide range of metabolites, some of which will be directly toxic and some of which will produce metabolites that lie in monoamine biosynthesis pathways. Clearly we are a long way from being able to document any relationship between variation for drug sensitivity and ecological variables. The first step in that direction will be identification of the quantitative trait loci underlying pharmacological differences. This will be a daunting task, but is as feasible as any other complex trait, be it morphological or behavioral. Phenotypic correlation among lines. Lines join points representing the mean time of death for both sexes pooled of each isofemale line, normalized by subtracting the total mean and dividing by the standard deviation for each drug. Genetic correlations computed from the variance components are indicated in Table 2 . Generation means of caffeine sensitivity in crosses between lines in the absence of a sex difference for at least one parent. The plots are the same as in Figure 3 , except that the F2 and BC generations are removed so as to highlight the features discussed in the text. NS non significant * 0.01 < p < 0.05 ** 0.001 < p < 0.01 *** p < 0.001 F-ratios and significance are followed by proportion of the variance explained by each random effect (in brackets). 
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